2020 Q2 Form 10-Q Financial Statement
#000071456220000065 Filed on May 07, 2020
Income Statement
Concept | 2020 Q2 | 2020 Q1 | 2019 Q1 |
---|---|---|---|
Revenue | $39.26M | $41.40M | $32.62M |
YoY Change | 18.03% | 26.94% | 11.03% |
Cost Of Revenue | |||
YoY Change | |||
Gross Profit | |||
YoY Change | |||
Gross Profit Margin | |||
Selling, General & Admin | |||
YoY Change | |||
% of Gross Profit | |||
Research & Development | |||
YoY Change | |||
% of Gross Profit | |||
Depreciation & Amortization | $1.550M | $1.400M | $1.000M |
YoY Change | 50.49% | 40.0% | -3.85% |
% of Gross Profit | |||
Operating Expenses | |||
YoY Change | |||
Operating Profit | |||
YoY Change | |||
Interest Expense | $3.361M | $5.053M | $3.190M |
YoY Change | -4.16% | 58.4% | 67.54% |
% of Operating Profit | |||
Other Income/Expense, Net | |||
YoY Change | |||
Pretax Income | $14.82M | $15.20M | $11.90M |
YoY Change | -6.02% | 27.75% | 9.25% |
Income Tax | $2.899M | $3.020M | $2.217M |
% Of Pretax Income | 19.56% | 19.87% | 18.63% |
Net Earnings | $11.92M | $12.18M | $9.682M |
YoY Change | -5.13% | 25.81% | 8.14% |
Net Earnings / Revenue | 30.37% | 29.42% | 29.68% |
Basic Earnings Per Share | |||
Diluted Earnings Per Share | $868.8K | $886.5K | $788.3K |
COMMON SHARES | |||
Basic Shares Outstanding | 13.71M shares | 13.75M shares | 12.29M shares |
Diluted Shares Outstanding |
Balance Sheet
Concept | 2020 Q2 | 2020 Q1 | 2019 Q1 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | |||
YoY Change | |||
Cash & Equivalents | $386.5M | $211.0M | $54.63M |
Short-Term Investments | |||
Other Short-Term Assets | |||
YoY Change | |||
Inventory | |||
Prepaid Expenses | |||
Receivables | |||
Other Receivables | |||
Total Short-Term Assets | |||
YoY Change | |||
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $63.27M | $63.14M | $45.98M |
YoY Change | 38.56% | 37.33% | -3.76% |
Goodwill | $78.59M | $78.59M | $34.36M |
YoY Change | 128.76% | 128.76% | 0.0% |
Intangibles | $9.829M | $10.24M | $1.083M |
YoY Change | 914.34% | 845.15% | -29.08% |
Long-Term Investments | |||
YoY Change | |||
Other Assets | |||
YoY Change | |||
Total Long-Term Assets | |||
YoY Change | |||
TOTAL ASSETS | |||
Total Short-Term Assets | |||
Total Long-Term Assets | |||
Total Assets | $4.368B | $4.062B | $3.026B |
YoY Change | 42.55% | 34.27% | 2.33% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | |||
YoY Change | |||
Accrued Expenses | |||
YoY Change | |||
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $100.1M | $83.80M | $56.60M |
YoY Change | 65.45% | 48.06% | 94.5% |
Long-Term Debt Due | |||
YoY Change | |||
Total Short-Term Liabilities | $100.1M | $83.80M | $56.60M |
YoY Change | 65.45% | 48.06% | 94.5% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Other Long-Term Liabilities | $79.70M | $78.10M | $61.60M |
YoY Change | 26.71% | 26.79% | 10.99% |
Total Long-Term Liabilities | $79.70M | $78.10M | $61.60M |
YoY Change | 26.71% | 26.79% | 10.99% |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $100.1M | $83.80M | $56.60M |
Total Long-Term Liabilities | $79.70M | $78.10M | $61.60M |
Total Liabilities | $3.778B | $3.481B | $2.563B |
YoY Change | 46.07% | 35.82% | 0.83% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | $509.0M | $504.2M | $466.4M |
YoY Change | 7.71% | 8.11% | 8.06% |
Common Stock | $142.1M | $141.9M | $78.80M |
YoY Change | 79.89% | 80.08% | 1.5% |
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | $70.37M | $70.37M | $69.47M |
YoY Change | 1.29% | 1.29% | -0.52% |
Treasury Stock Shares | 2.361M shares | 2.361M shares | 2.342M shares |
Shareholders Equity | $590.3M | $581.8M | $462.8M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $4.368B | $4.062B | $3.026B |
YoY Change | 42.55% | 34.27% | 2.33% |
Cashflow Statement
Concept | 2020 Q2 | 2020 Q1 | 2019 Q1 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | $11.92M | $12.18M | $9.682M |
YoY Change | -5.13% | 25.81% | 8.14% |
Depreciation, Depletion And Amortization | $1.550M | $1.400M | $1.000M |
YoY Change | 50.49% | 40.0% | -3.85% |
Cash From Operating Activities | $14.03M | $25.68M | $14.03M |
YoY Change | 5.01% | 83.03% | 55.37% |
INVESTING ACTIVITIES | |||
Capital Expenditures | -$1.270M | $1.557M | $309.0K |
YoY Change | 111.67% | 403.88% | -28.47% |
Acquisitions | $0.00 | $0.00 | |
YoY Change | |||
Other Investing Activities | -$126.0M | $51.91M | -$22.15M |
YoY Change | 461.75% | -334.36% | 357.64% |
Cash From Investing Activities | -$127.3M | $50.35M | -$22.04M |
YoY Change | 452.87% | -328.45% | 318.2% |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | $7.142M | $6.258M | |
YoY Change | 14.13% | 0.19% | |
Common Stock Issuance & Retirement, Net | $1.724M | $315.0K | |
YoY Change | 447.3% | -19.44% | |
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | 288.7M | $7.580M | -$11.75M |
YoY Change | 1714.64% | -164.5% | -67.99% |
NET CHANGE | |||
Cash From Operating Activities | 14.03M | $25.68M | $14.03M |
Cash From Investing Activities | -127.3M | $50.35M | -$22.04M |
Cash From Financing Activities | 288.7M | $7.580M | -$11.75M |
Net Change In Cash | 175.5M | $83.61M | -$19.76M |
YoY Change | 2707.52% | -523.1% | -40.03% |
FREE CASH FLOW | |||
Cash From Operating Activities | $14.03M | $25.68M | $14.03M |
Capital Expenditures | -$1.270M | $1.557M | $309.0K |
Free Cash Flow | $15.30M | $24.12M | $13.72M |
YoY Change | 9.6% | 75.8% | 59.58% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2019Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
13741825 | shares |
CY2020Q1 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2020Q1 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
CY2020Q1 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q1 | |
CY2020Q1 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2020 | |
CY2020Q1 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2020-03-31 | |
CY2020Q1 | dei |
Document Type
DocumentType
|
10-Q | |
CY2020Q1 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0000714562 | |
CY2020Q2 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
13714524 | shares |
CY2020Q1 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2020Q1 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | |
CY2020Q1 | dei |
Entity Filer Category
EntityFilerCategory
|
Accelerated Filer | |
CY2020Q1 | dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | |
CY2020Q1 | dei |
Entity Registrant Name
EntityRegistrantName
|
FIRST FINANCIAL CORP /IN/ | |
CY2020Q1 | dei |
Entity Shell Company
EntityShellCompany
|
false | |
CY2020Q1 | dei |
Entity Small Business
EntitySmallBusiness
|
false | |
CY2020Q1 | thff |
Available For Sale Securities Debt Maturities With Maturity Date Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithMaturityDateAmortizedCost
|
361913000 | USD |
CY2020Q1 | thff |
Available For Sale Securities Debt Maturities With Maturity Date Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithMaturityDateFairValue
|
380130000 | USD |
CY2019Q1 | thff |
Covered Assets
CoveredAssets
|
1494000 | USD |
CY2020Q1 | thff |
Covered Assets
CoveredAssets
|
6347000 | USD |
CY2019Q1 | thff |
Defined Contribution Plan Employer Accrued Discretionary Contribution Amount
DefinedContributionPlanEmployerAccruedDiscretionaryContributionAmount
|
390000 | USD |
CY2020Q1 | thff |
Defined Contribution Plan Employer Accrued Discretionary Contribution Amount
DefinedContributionPlanEmployerAccruedDiscretionaryContributionAmount
|
412000 | USD |
CY2019Q1 | thff |
Federal Deposit Insurance Corporation Premium Expense Benefit
FederalDepositInsuranceCorporationPremiumExpenseBenefit
|
140000 | USD |
CY2020Q1 | thff |
Federal Deposit Insurance Corporation Premium Expense Benefit
FederalDepositInsuranceCorporationPremiumExpenseBenefit
|
-230000 | USD |
CY2019Q4 | thff |
Federal Funds Purchased Repurchase Agreements Notes Payable
FederalFundsPurchasedRepurchaseAgreementsNotesPayable
|
80119000 | USD |
CY2020Q1 | thff |
Federal Funds Purchased Repurchase Agreements Notes Payable
FederalFundsPurchasedRepurchaseAgreementsNotesPayable
|
83784000 | USD |
CY2019Q1 | thff |
Financing Receivable Impaired Troubled Debt Restructuring Additions During Period
FinancingReceivableImpairedTroubledDebtRestructuringAdditionsDuringPeriod
|
193000 | USD |
CY2019Q4 | thff |
Financing Receivable Recorded Investment
FinancingReceivableRecordedInvestment
|
2666442000 | USD |
CY2020Q1 | thff |
Financing Receivable Recorded Investment
FinancingReceivableRecordedInvestment
|
2630616000 | USD |
CY2020Q1 | thff |
Financing Receivable Impaired Troubled Debt Restructuring Additions During Period
FinancingReceivableImpairedTroubledDebtRestructuringAdditionsDuringPeriod
|
154000 | USD |
CY2019Q1 | thff |
Financing Receivable Impaired Troubled Debt Restructuring Payments During Period
FinancingReceivableImpairedTroubledDebtRestructuringPaymentsDuringPeriod
|
193000 | USD |
CY2020Q1 | thff |
Financing Receivable Impaired Troubled Debt Restructuring Payments During Period
FinancingReceivableImpairedTroubledDebtRestructuringPaymentsDuringPeriod
|
151000 | USD |
CY2019Q4 | thff |
Impaired Financing Receivable Loan Losses Alocated
ImpairedFinancingReceivableLoanLossesAlocated
|
48000 | USD |
CY2020Q1 | thff |
Impaired Financing Receivable Loan Losses Alocated
ImpairedFinancingReceivableLoanLossesAlocated
|
42000 | USD |
CY2019Q4 | thff |
Impaired Financing Receivable Unpaid Principal Balance Fair Value Disclosure
ImpairedFinancingReceivableUnpaidPrincipalBalanceFairValueDisclosure
|
148000 | USD |
CY2020Q1 | thff |
Impaired Financing Receivable Unpaid Principal Balance Fair Value Disclosure
ImpairedFinancingReceivableUnpaidPrincipalBalanceFairValueDisclosure
|
141000 | USD |
CY2019Q4 | thff |
Loans And Leases Receivable Gross Consumer Excluding Mortgage And Home Equity
LoansAndLeasesReceivableGrossConsumerExcludingMortgageAndHomeEquity
|
386006000 | USD |
CY2020Q1 | thff |
Loans And Leases Receivable Gross Consumer Excluding Mortgage And Home Equity
LoansAndLeasesReceivableGrossConsumerExcludingMortgageAndHomeEquity
|
387980000 | USD |
CY2020Q1 | thff |
Loans And Leases Receivable Minimum Outstanding Balance To Be Individually Evaluated
LoansAndLeasesReceivableMinimumOutstandingBalanceToBeIndividuallyEvaluated
|
100000 | USD |
CY2019Q4 | thff |
Loans And Leases Receivable Residential
LoansAndLeasesReceivableResidential
|
682077000 | USD |
CY2020Q1 | thff |
Loans And Leases Receivable Residential
LoansAndLeasesReceivableResidential
|
663060000 | USD |
CY2019Q1 | thff |
Loansand Leases Disposals
LoansandLeasesDisposals
|
36000 | USD |
CY2020Q1 | thff |
Loansand Leases Disposals
LoansandLeasesDisposals
|
922000 | USD |
CY2019Q4 | thff |
Loansand Leases Receivable Netof Loanswith Deteriorated Credit Quality Covered
LoansandLeasesReceivableNetofLoanswithDeterioratedCreditQualityCovered
|
3200000 | USD |
CY2020Q1 | thff |
Loansand Leases Receivable Netof Loanswith Deteriorated Credit Quality Covered
LoansandLeasesReceivableNetofLoanswithDeterioratedCreditQualityCovered
|
2800000 | USD |
CY2020Q1 | thff |
Loansnotrated
Loansnotrated
|
2618380000 | USD |
CY2020Q1 | thff |
Other Comprehensive Income Loss Netof Tax Footnote
OtherComprehensiveIncomeLossNetofTaxFootnote
|
13502000 | USD |
CY2019 | thff |
Provision For Impaired Loan Losses
ProvisionForImpairedLoanLosses
|
689000 | USD |
CY2019Q1 | thff |
Provision For Loan And Lease Losses Excluding Fdic Indemnification Asset Changes
ProvisionForLoanAndLeaseLossesExcludingFDICIndemnificationAssetChanges
|
1470000 | USD |
CY2020Q1 | thff |
Provision For Loan And Lease Losses Excluding Fdic Indemnification Asset Changes
ProvisionForLoanAndLeaseLossesExcludingFDICIndemnificationAssetChanges
|
2690000 | USD |
CY2019Q1 | thff |
Recoveryofsecurityforpreviouslywrittenoff Otti
RecoveryofsecurityforpreviouslywrittenoffOTTI
|
0 | USD |
CY2020Q1 | thff |
Recoveryofsecurityforpreviouslywrittenoff Otti
RecoveryofsecurityforpreviouslywrittenoffOTTI
|
0 | USD |
CY2019Q1 | thff |
Service Charges And Fees On Deposit Accounts
ServiceChargesAndFeesOnDepositAccounts
|
2624000 | USD |
CY2020Q1 | thff |
Service Charges And Fees On Deposit Accounts
ServiceChargesAndFeesOnDepositAccounts
|
2998000 | USD |
CY2019Q1 | thff |
Service Charges And Fees Other
ServiceChargesAndFeesOther
|
3114000 | USD |
CY2020Q1 | thff |
Service Charges And Fees Other
ServiceChargesAndFeesOther
|
3330000 | USD |
CY2019Q1 | thff |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodTotalFairValue
|
841000 | USD |
CY2020Q1 | thff |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodTotalFairValue
|
837000 | USD |
CY2020Q1 | thff |
Share Based Compensation Arrangement By Share Based Payment Award Incremental Vesting Rights Percentage For Second Year
ShareBasedCompensationArrangementByShareBasedPaymentAwardIncrementalVestingRightsPercentageForSecondYear
|
0.33 | |
CY2020Q1 | thff |
Share Based Compensation Arrangement By Share Based Payment Award Incremental Vesting Rights Percentage For Third Year
ShareBasedCompensationArrangementByShareBasedPaymentAwardIncrementalVestingRightsPercentageForThirdYear
|
0.34 | |
CY2020Q1 | thff |
Share Based Compensation Arrangement By Share Based Payment Award Vesting Rights Percentage For First Year
ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingRightsPercentageForFirstYear
|
0.33 | |
CY2019Q1 | thff |
Trust And Financial Services Revenue
TrustAndFinancialServicesRevenue
|
1204000 | USD |
CY2020Q1 | thff |
Trust And Financial Services Revenue
TrustAndFinancialServicesRevenue
|
1534000 | USD |
CY2018Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-23454000 | USD |
CY2019Q1 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-12927000 | USD |
CY2019Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-7501000 | USD |
CY2020Q1 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
6001000 | USD |
CY2019Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
139694000 | USD |
CY2020Q1 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
139898000 | USD |
CY2019Q1 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
900000 | USD |
CY2020Q1 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
1462000 | USD |
CY2019Q4 | us-gaap |
Assets
Assets
|
4023250000 | USD |
CY2020Q1 | us-gaap |
Assets
Assets
|
4062414000 | USD |
CY2019Q4 | us-gaap |
Available For Sale Securities
AvailableForSaleSecurities
|
926717000 | USD |
CY2020Q1 | us-gaap |
Available For Sale Securities
AvailableForSaleSecurities
|
932041000 | USD |
CY2019Q4 | us-gaap |
Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
|
20976000 | USD |
CY2020Q1 | us-gaap |
Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
|
36784000 | USD |
CY2019Q4 | us-gaap |
Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
|
1834000 | USD |
CY2020Q1 | us-gaap |
Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
|
446000 | USD |
CY2019Q4 | us-gaap |
Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
|
907575000 | USD |
CY2020Q1 | us-gaap |
Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
|
895703000 | USD |
CY2019Q4 | us-gaap |
Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
|
1061000 | USD |
CY2020Q1 | us-gaap |
Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
|
57000 | USD |
CY2019Q4 | us-gaap |
Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
|
1834000 | USD |
CY2020Q1 | us-gaap |
Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
|
446000 | USD |
CY2019Q4 | us-gaap |
Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
|
212599000 | USD |
CY2020Q1 | us-gaap |
Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
|
21985000 | USD |
CY2019Q4 | us-gaap |
Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
|
773000 | USD |
CY2020Q1 | us-gaap |
Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
|
389000 | USD |
CY2019Q4 | us-gaap |
Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
|
131633000 | USD |
CY2020Q1 | us-gaap |
Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
|
21521000 | USD |
CY2019Q4 | us-gaap |
Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
|
80966000 | USD |
CY2020Q1 | us-gaap |
Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
|
464000 | USD |
CY2020Q1 | us-gaap |
Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
|
43921000 | USD |
CY2020Q1 | us-gaap |
Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
|
45180000 | USD |
CY2020Q1 | us-gaap |
Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
|
57759000 | USD |
CY2020Q1 | us-gaap |
Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
|
59055000 | USD |
CY2020Q1 | us-gaap |
Available For Sale Securities Debt Maturities After Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost
|
249936000 | USD |
CY2020Q1 | us-gaap |
Available For Sale Securities Debt Maturities After Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
|
265536000 | USD |
CY2020Q1 | us-gaap |
Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
|
10297000 | USD |
CY2020Q1 | us-gaap |
Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
|
10359000 | USD |
CY2020Q1 | us-gaap |
Available For Sale Securities Debt Maturities Without Single Maturity Date Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost
|
533790000 | USD |
CY2020Q1 | us-gaap |
Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
|
551911000 | USD |
CY2019Q4 | us-gaap |
Bank Owned Life Insurance
BankOwnedLifeInsurance
|
94251000 | USD |
CY2020Q1 | us-gaap |
Bank Owned Life Insurance
BankOwnedLifeInsurance
|
94633000 | USD |
CY2019Q4 | us-gaap |
Cash And Due From Banks
CashAndDueFromBanks
|
127426000 | USD |
CY2020Q1 | us-gaap |
Cash And Due From Banks
CashAndDueFromBanks
|
211034000 | USD |
CY2018Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
74388000 | USD |
CY2019Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
54627000 | USD |
CY2019Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
127426000 | USD |
CY2020Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
211034000 | USD |
CY2019Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
-19761000 | USD |
CY2020Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
83608000 | USD |
CY2019Q1 | us-gaap |
Certain Loans Acquired In Transfer Not Accounted For As Debt Securities Accretable Yield Accretion
CertainLoansAcquiredInTransferNotAccountedForAsDebtSecuritiesAccretableYieldAccretion
|
0 | USD |
CY2020Q1 | us-gaap |
Certain Loans Acquired In Transfer Not Accounted For As Debt Securities Accretable Yield Accretion
CertainLoansAcquiredInTransferNotAccountedForAsDebtSecuritiesAccretableYieldAccretion
|
0 | USD |
CY2019Q1 | us-gaap |
Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
|
0 | |
CY2020Q1 | us-gaap |
Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
|
0 | |
CY2019Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.125 | |
CY2020Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.125 | |
CY2019Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
40000000 | shares |
CY2020Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
40000000 | shares |
CY2019Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
16055466 | shares |
CY2020Q1 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
16075154 | shares |
CY2020Q1 | us-gaap |
Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
|
1334000 | USD |
CY2019Q1 | us-gaap |
Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
|
2109000 | USD |
CY2020Q1 | us-gaap |
Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
|
2904000 | USD |
CY2020Q1 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
13714524 | shares |
CY2019Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
2005000 | USD |
CY2020Q1 | us-gaap |
Common Stock Value
CommonStockValue
|
2005000 | USD |
CY2019Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
20209000 | USD |
CY2020Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
25683000 | USD |
CY2019Q1 | us-gaap |
Debt And Equity Securities Gain Loss
DebtAndEquitySecuritiesGainLoss
|
-4000 | USD |
CY2020Q1 | us-gaap |
Debt And Equity Securities Gain Loss
DebtAndEquitySecuritiesGainLoss
|
194000 | USD |
CY2019Q1 | us-gaap |
Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
|
2000 | USD |
CY2020Q1 | us-gaap |
Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
|
244000 | USD |
CY2019Q4 | us-gaap |
Defined Benefit Plan Expected Future Benefit Payments Next Twelve Months
DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths
|
3700000 | USD |
CY2019Q4 | us-gaap |
Defined Benefit Plan Expected Future Benefit Payments Remainder Of Fiscal Year
DefinedBenefitPlanExpectedFutureBenefitPaymentsRemainderOfFiscalYear
|
736000 | USD |
CY2019Q4 | us-gaap |
Deposits
Deposits
|
3275357000 | USD |
CY2020Q1 | us-gaap |
Deposits
Deposits
|
3291231000 | USD |
CY2019Q1 | us-gaap |
Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
|
1000000 | USD |
CY2020Q1 | us-gaap |
Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
|
1400000 | USD |
CY2019Q1 | us-gaap |
Dividends Common Stock Cash
DividendsCommonStockCash
|
0 | USD |
CY2020Q1 | us-gaap |
Dividends Common Stock Cash
DividendsCommonStockCash
|
0 | USD |
CY2019Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
0.79 | |
CY2020Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
0.89 | |
CY2019Q1 | us-gaap |
Equipment Expense
EquipmentExpense
|
1817000 | USD |
CY2020Q1 | us-gaap |
Equipment Expense
EquipmentExpense
|
2461000 | USD |
CY2019 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Earnings1
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
|
0 | USD |
CY2020Q1 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Earnings1
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
|
0 | USD |
CY2019 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Other Comprehensive Income Loss
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss
|
498000 | USD |
CY2020Q1 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Other Comprehensive Income Loss
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss
|
-386000 | USD |
CY2019 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
|
0 | USD |
CY2019 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
|
707000 | USD |
CY2020Q1 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
|
330000 | USD |
CY2020Q1 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
|
0 | USD |
CY2018Q4 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
|
6393000 | USD |
CY2019Q4 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
|
6184000 | USD |
CY2020Q1 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
|
5468000 | USD |
CY2019Q4 | us-gaap |
Federal Funds Purchased
FederalFundsPurchased
|
900000 | USD |
CY2020Q1 | us-gaap |
Federal Funds Purchased
FederalFundsPurchased
|
2150000 | USD |
CY2019Q4 | us-gaap |
Federal Funds Purchased And Securities Sold Under Agreements To Repurchase
FederalFundsPurchasedAndSecuritiesSoldUnderAgreementsToRepurchase
|
80119000 | USD |
CY2020Q1 | us-gaap |
Federal Funds Purchased And Securities Sold Under Agreements To Repurchase
FederalFundsPurchasedAndSecuritiesSoldUnderAgreementsToRepurchase
|
83784000 | USD |
CY2019Q4 | us-gaap |
Federal Funds Sold
FederalFundsSold
|
7500000 | USD |
CY2020Q1 | us-gaap |
Federal Funds Sold
FederalFundsSold
|
1000 | USD |
CY2019Q4 | us-gaap |
Federal Home Loan Bank Advances Branch Of Fhlb Bank Amount Of Advances By Branch
FederalHomeLoanBankAdvancesBranchOfFHLBBankAmountOfAdvancesByBranch
|
30973000 | USD |
CY2020Q1 | us-gaap |
Federal Home Loan Bank Advances Branch Of Fhlb Bank Amount Of Advances By Branch
FederalHomeLoanBankAdvancesBranchOfFHLBBankAmountOfAdvancesByBranch
|
27494000 | USD |
CY2019Q4 | us-gaap |
Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
|
19895000 | USD |
CY2020Q1 | us-gaap |
Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
|
21021000 | USD |
CY2019Q4 | us-gaap |
Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
|
48000 | USD |
CY2020Q1 | us-gaap |
Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
|
42000 | USD |
CY2019Q1 | us-gaap |
Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
|
1163000 | USD |
CY2019Q4 | us-gaap |
Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
|
2651893000 | USD |
CY2020Q1 | us-gaap |
Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
|
2614336000 | USD |
CY2019Q4 | us-gaap |
Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
|
7113000 | USD |
CY2020Q1 | us-gaap |
Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
|
9731000 | USD |
CY2018Q4 | us-gaap |
Financing Receivable Modifications Recorded Investment
FinancingReceivableModificationsRecordedInvestment
|
4806000 | USD |
CY2019Q1 | us-gaap |
Financing Receivable Modifications Recorded Investment
FinancingReceivableModificationsRecordedInvestment
|
4774000 | USD |
CY2019Q4 | us-gaap |
Financing Receivable Modifications Recorded Investment
FinancingReceivableModificationsRecordedInvestment
|
4194000 | USD |
CY2020Q1 | us-gaap |
Financing Receivable Modifications Recorded Investment
FinancingReceivableModificationsRecordedInvestment
|
4156000 | USD |
CY2019Q4 | us-gaap |
Financing Receivable Recorded Investment Current
FinancingReceivableRecordedInvestmentCurrent
|
2634852000 | USD |
CY2020Q1 | us-gaap |
Financing Receivable Recorded Investment Current
FinancingReceivableRecordedInvestmentCurrent
|
2597677000 | USD |
CY2019Q4 | us-gaap |
Financing Receivable Recorded Investment Past Due
FinancingReceivableRecordedInvestmentPastDue
|
31590000 | USD |
CY2020Q1 | us-gaap |
Financing Receivable Recorded Investment Past Due
FinancingReceivableRecordedInvestmentPastDue
|
32939000 | USD |
CY2019Q1 | us-gaap |
Financing Receivables Impaired Troubled Debt Restructuring Write Down
FinancingReceivablesImpairedTroubledDebtRestructuringWriteDown
|
32000 | USD |
CY2020Q1 | us-gaap |
Financing Receivables Impaired Troubled Debt Restructuring Write Down
FinancingReceivablesImpairedTroubledDebtRestructuringWriteDown
|
41000 | USD |
CY2019Q1 | us-gaap |
Gain Loss On Sale Of Mortgage Loans
GainLossOnSaleOfMortgageLoans
|
420000 | USD |
CY2020Q1 | us-gaap |
Gain Loss On Sale Of Mortgage Loans
GainLossOnSaleOfMortgageLoans
|
698000 | USD |
CY2019Q1 | us-gaap |
Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
|
-8000 | USD |
CY2020Q1 | us-gaap |
Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
|
-23000 | USD |
CY2019Q4 | us-gaap |
Goodwill
Goodwill
|
78592000 | USD |
CY2020Q1 | us-gaap |
Goodwill
Goodwill
|
78592000 | USD |
CY2019Q1 | us-gaap |
Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
|
11831000 | USD |
CY2019 | us-gaap |
Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
|
8693000 | USD |
CY2020Q1 | us-gaap |
Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
|
8424000 | USD |
CY2019Q1 | us-gaap |
Impaired Financing Receivable Interest Income Accrual Method
ImpairedFinancingReceivableInterestIncomeAccrualMethod
|
0 | USD |
CY2019 | us-gaap |
Impaired Financing Receivable Interest Income Accrual Method
ImpairedFinancingReceivableInterestIncomeAccrualMethod
|
0 | USD |
CY2020Q1 | us-gaap |
Impaired Financing Receivable Interest Income Accrual Method
ImpairedFinancingReceivableInterestIncomeAccrualMethod
|
0 | USD |
CY2019Q1 | us-gaap |
Impaired Financing Receivable Interest Income Cash Basis Method
ImpairedFinancingReceivableInterestIncomeCashBasisMethod
|
0 | USD |
CY2019 | us-gaap |
Impaired Financing Receivable Interest Income Cash Basis Method
ImpairedFinancingReceivableInterestIncomeCashBasisMethod
|
0 | USD |
CY2020Q1 | us-gaap |
Impaired Financing Receivable Interest Income Cash Basis Method
ImpairedFinancingReceivableInterestIncomeCashBasisMethod
|
0 | USD |
CY2019Q4 | us-gaap |
Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
|
7113000 | USD |
CY2020Q1 | us-gaap |
Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
|
9731000 | USD |
CY2019Q4 | us-gaap |
Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
|
48000 | USD |
CY2020Q1 | us-gaap |
Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
|
42000 | USD |
CY2019Q4 | us-gaap |
Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
|
7643000 | USD |
CY2020Q1 | us-gaap |
Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
|
10261000 | USD |
CY2019Q4 | us-gaap |
Impaired Financing Receivable With Related Allowance Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment
|
100000 | USD |
CY2020Q1 | us-gaap |
Impaired Financing Receivable With Related Allowance Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment
|
99000 | USD |
CY2019Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
11899000 | USD |
CY2020Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
15201000 | USD |
CY2019Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
2217000 | USD |
CY2020Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
3020000 | USD |
CY2019Q1 | us-gaap |
Increase Decrease In Deposits
IncreaseDecreaseInDeposits
|
-17171000 | USD |
CY2020Q1 | us-gaap |
Increase Decrease In Deposits
IncreaseDecreaseInDeposits
|
16281000 | USD |
CY2019Q1 | us-gaap |
Increase Decrease In Federal Funds Sold
IncreaseDecreaseInFederalFundsSold
|
-2000000 | USD |
CY2020Q1 | us-gaap |
Increase Decrease In Federal Funds Sold
IncreaseDecreaseInFederalFundsSold
|
7499000 | USD |
CY2019Q4 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
10643000 | USD |
CY2020Q1 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
10236000 | USD |
CY2019Q1 | us-gaap |
Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
|
32616000 | USD |
CY2020Q1 | us-gaap |
Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
|
41403000 | USD |
CY2019Q1 | us-gaap |
Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
|
26754000 | USD |
CY2020Q1 | us-gaap |
Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
|
35034000 | USD |
CY2019Q4 | us-gaap |
Interest Bearing Domestic Deposit Certificates Of Deposits
InterestBearingDomesticDepositCertificatesOfDeposits
|
126738000 | USD |
CY2020Q1 | us-gaap |
Interest Bearing Domestic Deposit Certificates Of Deposits
InterestBearingDomesticDepositCertificatesOfDeposits
|
118162000 | USD |
CY2019Q1 | us-gaap |
Interest Expense
InterestExpense
|
3190000 | USD |
CY2020Q1 | us-gaap |
Interest Expense
InterestExpense
|
5053000 | USD |
CY2019Q1 | us-gaap |
Interest Expense Deposits
InterestExpenseDeposits
|
2817000 | USD |
CY2020Q1 | us-gaap |
Interest Expense Deposits
InterestExpenseDeposits
|
4530000 | USD |
CY2019Q1 | us-gaap |
Interest Expense Other
InterestExpenseOther
|
50000 | USD |
CY2020Q1 | us-gaap |
Interest Expense Other
InterestExpenseOther
|
256000 | USD |
CY2019Q1 | us-gaap |
Interest Expense Short Term Borrowings
InterestExpenseShortTermBorrowings
|
323000 | USD |
CY2020Q1 | us-gaap |
Interest Expense Short Term Borrowings
InterestExpenseShortTermBorrowings
|
267000 | USD |
CY2019Q1 | us-gaap |
Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
|
27956000 | USD |
CY2020Q1 | us-gaap |
Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
|
33660000 | USD |
CY2019Q1 | us-gaap |
Interest Income Expense Net
InterestIncomeExpenseNet
|
29426000 | USD |
CY2020Q1 | us-gaap |
Interest Income Expense Net
InterestIncomeExpenseNet
|
36350000 | USD |
CY2019Q1 | us-gaap |
Interest Income Securities Tax Exempt
InterestIncomeSecuritiesTaxExempt
|
1867000 | USD |
CY2020Q1 | us-gaap |
Interest Income Securities Tax Exempt
InterestIncomeSecuritiesTaxExempt
|
1938000 | USD |
CY2019Q1 | us-gaap |
Interest Income Securities Taxable
InterestIncomeSecuritiesTaxable
|
3681000 | USD |
CY2020Q1 | us-gaap |
Interest Income Securities Taxable
InterestIncomeSecuritiesTaxable
|
4029000 | USD |
CY2019Q4 | us-gaap |
Interest Receivable
InterestReceivable
|
18523000 | USD |
CY2020Q1 | us-gaap |
Interest Receivable
InterestReceivable
|
17098000 | USD |
CY2019Q4 | us-gaap |
Interestbearing Domestic Deposit Other
InterestbearingDomesticDepositOther
|
2601430000 | USD |
CY2020Q1 | us-gaap |
Interestbearing Domestic Deposit Other
InterestbearingDomesticDepositOther
|
2641311000 | USD |
CY2019Q1 | us-gaap |
Labor And Related Expense
LaborAndRelatedExpense
|
12755000 | USD |
CY2020Q1 | us-gaap |
Labor And Related Expense
LaborAndRelatedExpense
|
15972000 | USD |
CY2019Q4 | us-gaap |
Liabilities
Liabilities
|
3465642000 | USD |
CY2020Q1 | us-gaap |
Liabilities
Liabilities
|
3480643000 | USD |
CY2019Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
4023250000 | USD |
CY2020Q1 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
4062414000 | USD |
CY2018Q4 | us-gaap |
Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
|
20436000 | USD |
CY2019Q1 | us-gaap |
Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
|
20960000 | USD |
CY2019Q4 | us-gaap |
Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
|
19943000 | USD |
CY2020Q1 | us-gaap |
Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
|
21063000 | USD |
CY2019Q4 | us-gaap |
Loans And Leases Receivable Deferred Income
LoansAndLeasesReceivableDeferredIncome
|
-3860000 | USD |
CY2020Q1 | us-gaap |
Loans And Leases Receivable Deferred Income
LoansAndLeasesReceivableDeferredIncome
|
-4257000 | USD |
CY2019Q4 | us-gaap |
Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
|
2652530000 | USD |
CY2020Q1 | us-gaap |
Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
|
2618380000 | USD |
CY2018Q4 | us-gaap |
Loans And Leases Receivable Gross Carrying Amount Covered
LoansAndLeasesReceivableGrossCarryingAmountCovered
|
1530000 | USD |
CY2019Q4 | us-gaap |
Loans And Leases Receivable Gross Carrying Amount Covered
LoansAndLeasesReceivableGrossCarryingAmountCovered
|
7269000 | USD |
CY2019Q4 | us-gaap |
Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
|
2636447000 | USD |
CY2020Q1 | us-gaap |
Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
|
2601574000 | USD |
CY2019Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-11752000 | USD |
CY2020Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
7580000 | USD |
CY2019Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-22039000 | USD |
CY2020Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
50349000 | USD |
CY2019Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
14030000 | USD |
CY2020Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
25679000 | USD |
CY2019Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
9682000 | USD |
CY2020Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
12181000 | USD |
CY2019Q4 | us-gaap |
Noninterest Bearing Deposit Liabilities
NoninterestBearingDepositLiabilities
|
547189000 | USD |
CY2020Q1 | us-gaap |
Noninterest Bearing Deposit Liabilities
NoninterestBearingDepositLiabilities
|
531758000 | USD |
CY2019Q1 | us-gaap |
Noninterest Expense
NoninterestExpense
|
23693000 | USD |
CY2020Q1 | us-gaap |
Noninterest Expense
NoninterestExpense
|
27554000 | USD |
CY2019Q1 | us-gaap |
Noninterest Income
NoninterestIncome
|
7636000 | USD |
CY2020Q1 | us-gaap |
Noninterest Income
NoninterestIncome
|
9095000 | USD |
CY2019Q1 | us-gaap |
Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
|
278000 | USD |
CY2020Q1 | us-gaap |
Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
|
341000 | USD |
CY2019Q4 | us-gaap |
Notes And Loans Receivable Gross Current
NotesAndLoansReceivableGrossCurrent
|
1584447000 | USD |
CY2020Q1 | us-gaap |
Notes And Loans Receivable Gross Current
NotesAndLoansReceivableGrossCurrent
|
1567340000 | USD |
CY2020Q1 | us-gaap |
Number Of Reportable Segments
NumberOfReportableSegments
|
1 | segment |
CY2019Q1 | us-gaap |
Occupancy Net
OccupancyNet
|
1815000 | USD |
CY2020Q1 | us-gaap |
Occupancy Net
OccupancyNet
|
1929000 | USD |
CY2019Q4 | us-gaap |
Other Assets
OtherAssets
|
41556000 | USD |
CY2020Q1 | us-gaap |
Other Assets
OtherAssets
|
34771000 | USD |
CY2019Q1 | us-gaap |
Other Comprehensive Income Availableforsale Securities Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent
|
10224000 | USD |
CY2020Q1 | us-gaap |
Other Comprehensive Income Availableforsale Securities Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent
|
13098000 | USD |
CY2019Q1 | us-gaap |
Other Comprehensive Income Defined Benefit Plans Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentBeforeTaxPortionAttributableToParent
|
-303000 | USD |
CY2020Q1 | us-gaap |
Other Comprehensive Income Defined Benefit Plans Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentBeforeTaxPortionAttributableToParent
|
-404000 | USD |
CY2019Q1 | us-gaap |
Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
|
10221000 | USD |
CY2020Q1 | us-gaap |
Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
|
13244000 | USD |
CY2019Q1 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
10527000 | USD |
CY2020Q1 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
13502000 | USD |
CY2019Q1 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
10527000 | USD |
CY2020Q1 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
13502000 | USD |
CY2019Q1 | us-gaap |
Other Interest And Dividend Income
OtherInterestAndDividendIncome
|
314000 | USD |
CY2020Q1 | us-gaap |
Other Interest And Dividend Income
OtherInterestAndDividendIncome
|
402000 | USD |
CY2019Q4 | us-gaap |
Other Liabilities
OtherLiabilities
|
79193000 | USD |
CY2020Q1 | us-gaap |
Other Liabilities
OtherLiabilities
|
78134000 | USD |
CY2019Q1 | us-gaap |
Other Noninterest Expense
OtherNoninterestExpense
|
7166000 | USD |
CY2020Q1 | us-gaap |
Other Noninterest Expense
OtherNoninterestExpense
|
7422000 | USD |
CY2019Q1 | us-gaap |
Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
|
1185000 | USD |
CY2020Q1 | us-gaap |
Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
|
8611000 | USD |
CY2019Q4 | us-gaap |
Other Real Estate
OtherRealEstate
|
3625000 | USD |
CY2020Q1 | us-gaap |
Other Real Estate
OtherRealEstate
|
3894000 | USD |
CY2019Q1 | us-gaap |
Other Than Temporary Impairment Credit Losses Recognized In Earnings Additions No Previous Impairment
OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsAdditionsNoPreviousImpairment
|
0 | USD |
CY2020Q1 | us-gaap |
Other Than Temporary Impairment Credit Losses Recognized In Earnings Additions No Previous Impairment
OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsAdditionsNoPreviousImpairment
|
0 | USD |
CY2018Q4 | us-gaap |
Other Than Temporary Impairment Credit Losses Recognized In Earnings Credit Losses On Debt Securities Held
OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld
|
2974000 | USD |
CY2019Q1 | us-gaap |
Other Than Temporary Impairment Credit Losses Recognized In Earnings Credit Losses On Debt Securities Held
OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld
|
2974000 | USD |
CY2019Q4 | us-gaap |
Other Than Temporary Impairment Credit Losses Recognized In Earnings Credit Losses On Debt Securities Held
OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld
|
2974000 | USD |
CY2020Q1 | us-gaap |
Other Than Temporary Impairment Credit Losses Recognized In Earnings Credit Losses On Debt Securities Held
OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld
|
2974000 | USD |
CY2019Q1 | us-gaap |
Other Than Temporary Impairment Credit Losses Recognized In Earnings Reductions Cash Flows
OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsReductionsCashFlows
|
0 | USD |
CY2020Q1 | us-gaap |
Other Than Temporary Impairment Credit Losses Recognized In Earnings Reductions Cash Flows
OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsReductionsCashFlows
|
0 | USD |
CY2019Q1 | us-gaap |
Other Than Temporary Impairment Credit Losses Recognized In Earnings Reductions Securities Sold
OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsReductionsSecuritiesSold
|
0 | USD |
CY2020Q1 | us-gaap |
Other Than Temporary Impairment Credit Losses Recognized In Earnings Reductions Securities Sold
OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsReductionsSecuritiesSold
|
0 | USD |
CY2019Q1 | us-gaap |
Payments For Proceeds From Loans And Leases
PaymentsForProceedsFromLoansAndLeases
|
30828000 | USD |
CY2020Q1 | us-gaap |
Payments For Proceeds From Loans And Leases
PaymentsForProceedsFromLoansAndLeases
|
-33764000 | USD |
CY2019Q1 | us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
315000 | USD |
CY2020Q1 | us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
1724000 | USD |
CY2019Q1 | us-gaap |
Payments Of Dividends
PaymentsOfDividends
|
6258000 | USD |
CY2020Q1 | us-gaap |
Payments Of Dividends
PaymentsOfDividends
|
7142000 | USD |
CY2019Q1 | us-gaap |
Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
|
16214000 | USD |
CY2020Q1 | us-gaap |
Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
|
63516000 | USD |
CY2019Q1 | us-gaap |
Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
|
0 | USD |
CY2020Q1 | us-gaap |
Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
|
0 | USD |
CY2019Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
309000 | USD |
CY2020Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
1557000 | USD |
CY2019Q1 | us-gaap |
Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
|
22000 | USD |
CY2020Q1 | us-gaap |
Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
|
6000 | USD |
CY2019Q1 | us-gaap |
Proceeds From Federal Home Loan Bank Borrowings
ProceedsFromFederalHomeLoanBankBorrowings
|
117000000 | USD |
CY2020Q1 | us-gaap |
Proceeds From Federal Home Loan Bank Borrowings
ProceedsFromFederalHomeLoanBankBorrowings
|
1500000 | USD |
CY2019Q1 | us-gaap |
Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
|
27321000 | USD |
CY2020Q1 | us-gaap |
Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
|
46517000 | USD |
CY2019Q1 | us-gaap |
Proceeds From Payments For In Securities Sold Under Agreements To Repurchase
ProceedsFromPaymentsForInSecuritiesSoldUnderAgreementsToRepurchase
|
-13008000 | USD |
CY2020Q1 | us-gaap |
Proceeds From Payments For In Securities Sold Under Agreements To Repurchase
ProceedsFromPaymentsForInSecuritiesSoldUnderAgreementsToRepurchase
|
3665000 | USD |
CY2019Q1 | us-gaap |
Proceeds From Sale Of Other Real Estate
ProceedsFromSaleOfOtherRealEstate
|
13000 | USD |
CY2020Q1 | us-gaap |
Proceeds From Sale Of Other Real Estate
ProceedsFromSaleOfOtherRealEstate
|
44000 | USD |
CY2019Q1 | us-gaap |
Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
|
0 | USD |
CY2020Q1 | us-gaap |
Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
|
0 | USD |
CY2019Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
62576000 | USD |
CY2020Q1 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
63140000 | USD |
CY2019Q1 | us-gaap |
Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
|
1470000 | USD |
CY2020Q1 | us-gaap |
Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
|
2690000 | USD |
CY2019Q1 | us-gaap |
Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
|
-306000 | USD |
CY2020Q1 | us-gaap |
Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
|
-258000 | USD |
CY2019Q1 | us-gaap |
Repayments Of Federal Home Loan Bank Borrowings
RepaymentsOfFederalHomeLoanBankBorrowings
|
92000000 | USD |
CY2020Q1 | us-gaap |
Repayments Of Federal Home Loan Bank Borrowings
RepaymentsOfFederalHomeLoanBankBorrowings
|
5000000 | USD |
CY2019Q4 | us-gaap |
Restricted Investments
RestrictedInvestments
|
15394000 | USD |
CY2020Q1 | us-gaap |
Restricted Investments
RestrictedInvestments
|
15400000 | USD |
CY2019Q1 | us-gaap |
Restricted Stock Expense
RestrictedStockExpense
|
201000 | USD |
CY2020Q1 | us-gaap |
Restricted Stock Expense
RestrictedStockExpense
|
204000 | USD |
CY2019Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
492055000 | USD |
CY2020Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
504236000 | USD |
CY2019Q4 | us-gaap |
Securities Sold Under Agreements To Repurchase
SecuritiesSoldUnderAgreementsToRepurchase
|
79219000 | USD |
CY2020Q1 | us-gaap |
Securities Sold Under Agreements To Repurchase
SecuritiesSoldUnderAgreementsToRepurchase
|
81634000 | USD |
CY2020Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
|
P3Y | |
CY2019Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
|
19783 | shares |
CY2020Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
|
19688 | shares |
CY2019Q1 | us-gaap |
Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
|
201000 | USD |
CY2020Q1 | us-gaap |
Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
|
204000 | USD |
CY2018Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
442701000 | USD |
CY2019Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
462796000 | USD |
CY2019Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
557608000 | USD |
CY2020Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
581771000 | USD |
CY2019Q4 | us-gaap |
Treasury Stock Shares
TreasuryStockShares
|
2313641 | shares |
CY2020Q1 | us-gaap |
Treasury Stock Shares
TreasuryStockShares
|
2360630 | shares |
CY2019Q1 | us-gaap |
Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
|
7866 | shares |
CY2020Q1 | us-gaap |
Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
|
46989 | shares |
CY2019Q4 | us-gaap |
Treasury Stock Value
TreasuryStockValue
|
68645000 | USD |
CY2020Q1 | us-gaap |
Treasury Stock Value
TreasuryStockValue
|
70369000 | USD |
CY2019Q1 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
12282000 | shares |
CY2020Q1 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
13740000 | shares |
CY2020Q1 | us-gaap |
Description Of New Accounting Pronouncements Not Yet Adopted
DescriptionOfNewAccountingPronouncementsNotYetAdopted
|
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">New accounting standards</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accounting Pronouncements Adopted:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In January 2017, the FASB issued ASU No. 2017-04, Simplifying the Test for Goodwill Impairment. The guidance removes Step 2 of the goodwill impairment test, which requires a hypothetical purchase price allocation. Goodwill impairment will now be the amount by which a reporting unit’s carrying value exceeds its fair value, not to exceed the carrying amount of goodwill. All other goodwill impairment guidance will remain largely unchanged. ASU No. 2017-04 is effective for interim and annual reporting periods beginning after December 15, 2019, applied prospectively. Early adoption is permitted for any impairment tests performed after January 1, 2017. The Corporation adopted ASU 2017-04 on January 1, 2020. There was not a significant impact to accounting and disclosures.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2018, the FASB issued ASU No. 2018-13, Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement.</font><font style="font-family:inherit;font-size:10pt;font-style:italic;"> </font><font style="font-family:inherit;font-size:10pt;">This ASU eliminates, adds and modifies certain disclosure requirements for fair value measurements. Among the changes, entities will no longer be required to disclose the amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy, but will be required to disclose the range and weighted average used to develop significant unobservable inputs for Level 3 fair value measurements. ASU No. 2018-13 is effective for interim and annual reporting periods beginning after December 15, 2019; early adoption is permitted. The Corporation adopted ASU 2018-13 on January 1, 2020. As ASU No. 2018-13 only revises disclosure requirements, it did not have a material impact on the Corporation’s financial statements.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In September 2018, the FASB issued ASU No. 2018-15, Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract. This ASU requires an entity in a cloud computing arrangement (i.e., hosting arrangement) that is a service contract to follow the internal-use software guidance in ASC 350-40 to determine which implementation costs to capitalize as assets or expense as incurred. Capitalized implementation costs should be presented in the same line item on the balance sheet as amounts prepaid for the hosted service, if any (generally as an “other asset”). The capitalized costs will be amortized over the term of the hosting arrangement, with the amortization expense being presented in the same income statement line item as the fees paid for the hosted service. ASU 2018-15 is effective for interim and annual reporting periods beginning after December 15, 2019; early adoption is permitted. The Corporation adopted ASU 2018-15 on January 1, 2020. ASU 2018-15 did not have a material impact on the Corporation’s financial statements.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Recent Accounting Pronouncements:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In June 2016 ASU 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Instruments (ASU 2016-13), was issued and requires entities to use a current expected credit loss ("CECL") model which is a</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">new impairment model based on expected losses rather than incurred losses. Under this model an entity would recognize an</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">impairment allowance equal to its current estimate of all contractual cash flows that the entity does not expect to collect from</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">financial assets measured at amortized cost. The entity's estimate would consider relevant information about past events,</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">current conditions, and reasonable and supportable forecasts, which will result in recognition of lifetime expected credit losses</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">upon loan origination. ASU 2016-13 is effective for interim and annual reporting periods beginning after December 15, 2019,</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">with early adoption permitted for annual reporting periods beginning after December 15, 2018.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#212529;">The Corporation formed a cross-functional internal management committee and engaged a third party vendor to assist with the</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#212529;">transition to the guidance set forth in this update. The new allowance model implemented by the Corporation estimates credit</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#212529;">losses over the expected life of the portfolio and includes a qualitative framework to account for the drivers of losses that are</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#212529;">not captured by the quantitative model. The results continue to be utilized to refine our models and estimation techniques.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#212529;">Documentation of new methodologies and internal controls that will be implemented as part of CECL as well as model</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#212529;">validation is also being finalized. While the committee continues to analyze and modify calculations, the Corporation currently</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#212529;">expects the adoption of ASU 2016-13 will result in an increase in allowance for loan losses amount at January 1, 2020 in the</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#212529;">range of $15 million to $25 million. The allowance for credit losses also increased due to the requirement to record an</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#212529;">allowance on acquired loan portfolios, previously recorded at fair value. Once finalized, the cumulative effect adjustment, as a</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#212529;">result of the adoption of this guidance, was originally to be recorded on January 1, 2020, net of tax, as an adjustment to retained earnings. This estimate is subject to change as key assumptions are refined and model validations are finalized.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (CARES Act) was signed by the President of the United States that included an option for entities to delay the implementation of ASU 2016-13 until the earlier of the termination date of the national emergency declaration by the President or December 31, 2020. Due to the uncertainty on the economy and unemployment from COVID-19, the Corporation has determined to delay its implementation of ASU 2016-13 and has calculated and recorded its provision for loan losses under the incurred loss model that existed prior to ASU 2016-13.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2018, the FASB issued ASU No. 2018-14, Disclosure Framework - Changes to the Disclosure Requirements for Defined Benefit Plans.</font><font style="font-family:inherit;font-size:10pt;font-style:italic;"> </font><font style="font-family:inherit;font-size:10pt;">This ASU makes minor changes to the disclosure requirements for employers that sponsor defined benefit pension and/or other postretirement benefit plans. ASU 2018-14 is effective for fiscal years ending after December 15, 2020; early adoption is permitted. As ASU 2018-14 only revises disclosure requirements, it will not have a material impact on the Corporation’s financial statements.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In December 2019, the FASB issued ASU 2019-12 “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes.” These amendments remove specific exceptions to the general principles in Topic 740 in GAAP. It eliminates the need for an organization to analyze whether the following apply in a given period: exception to the incremental approach for intraperiod tax allocation; exceptions to accounting for basis differences where there are ownership changes in foreign investments; and exception in interim period income tax accounting for year-to-date losses that exceed anticipated losses. It also improves financial statement preparers’ application of income tax-related guidance and simplifies GAAP for: franchise taxes that are partially based on income; transactions with a government that result in a step up in the tax basis of goodwill; separate financial statements of legal entities that are not subject to tax; and enacts changes in tax laws in interim periods. The guidance is effective for public business entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. Early adoption is permitted. The Corporation is assessing ASU 2019-12 and its impact on its accounting and disclosure.</font></div></div> |